Clinical Trial Update: Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety of intravitreal SOK583A1 in a prefilled syringe for neovascular age-related macular degeneration (nAMD) completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• SOK583A1

Snippet

Sponsor: Sandoz | Conditions: Neovascular Age-related Macular Degeneration (nAMD) | Phase 3 | Status: COMPLETED | Results posted: 2022-11-18